review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Arjang Djamali | |
Aparna Vidyasagar | |||
Surmeet Bedi | |||
P2860 | cites work | The natural history of chronic allograft nephropathy | Q44688416 |
Epithelial-to-mesenchymal transition and oxidative stress in chronic allograft nephropathy | Q45262222 | ||
Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis | Q46485566 | ||
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. | Q50654391 | ||
Death after graft loss: an important late study endpoint in kidney transplantation. | Q50711901 | ||
Rethinking chronic allograft nephropathy: the concept of accelerated senescence. | Q50847726 | ||
p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. | Q53388493 | ||
Risk Factors for Early Epithelial to Mesenchymal Transition in Renal Grafts | Q61859683 | ||
Myofibroblasts and the progression of diabetic nephropathy | Q73060201 | ||
Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis | Q77374112 | ||
Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction | Q77983643 | ||
Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition | Q78728261 | ||
Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy | Q79326178 | ||
Chronic allograft nephropathy | Q79359328 | ||
TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation | Q82040208 | ||
Chronic allograft nephropathy: intraepithelial signals generated by transforming growth factor-beta and bone morphogenetic protein-7 | Q83314660 | ||
Epithelial-mesenchymal transition and its implications for fibrosis | Q24302042 | ||
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE) | Q28366662 | ||
TGF-beta and epithelial-to-mesenchymal transitions | Q29616456 | ||
Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 | ||
Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes | Q34429805 | ||
Strategies to improve long-term outcomes after renal transplantation | Q34539775 | ||
Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition | Q34612862 | ||
Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention | Q35615604 | ||
The role of epithelial-to-mesenchymal transition in renal fibrosis | Q35643525 | ||
Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis | Q35746891 | ||
Polyomavirus nephropathy: what have we learned? | Q35787102 | ||
Chronic allograft nephropathy | Q36094077 | ||
Mechanisms of disease: Fibroblasts--a new look at an old problem | Q36577128 | ||
Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts | Q36802004 | ||
Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation | Q38289991 | ||
Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis | Q39814662 | ||
Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. | Q40464612 | ||
A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition | Q40493463 | ||
Transdifferentiation of cultured tubular cells induced by hypoxia | Q40590913 | ||
Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition | Q40595085 | ||
Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice | Q40633055 | ||
Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation | Q40646262 | ||
Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. | Q40721147 | ||
Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. | Q40818094 | ||
Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling | Q44298458 | ||
Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1,2 | Q44419285 | ||
BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury | Q44479221 | ||
P433 | issue | 1 | |
P304 | page(s) | 1-5 | |
P577 | publication date | 2008-01-01 | |
P1433 | published in | Transplantation Reviews | Q15749559 |
P1476 | title | Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis | |
P478 | volume | 22 |
Q39156698 | AEG-1 participates in TGF-beta1-induced EMT through p38 MAPK activation |
Q28307191 | Activation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosis |
Q47798176 | Adenosine receptors are up-regulated in unilateral ureteral obstructed rat kidneys |
Q39550813 | Adenovirus-mediated anti-sense ERK2 gene therapy inhibits tubular epithelial-mesenchymal transition and ameliorates renal allograft fibrosis |
Q34570605 | Analysis of machine perfusion benefits in kidney grafts: a preclinical study |
Q42849659 | Analysis of urinary gene expression of epithelial-mesenchymal transition markers in kidney transplant recipients. |
Q33593163 | Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model |
Q46895163 | Aristolochic Acid-Induced Autophagy Promotes Epithelial-to-Myofibroblast Transition in Human Renal Proximal Tubule Epithelial Cells. |
Q52934212 | BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation. |
Q43121574 | Bone marrow mononuclear cells attenuate fibrosis development after severe acute kidney injury |
Q43209162 | Characterization of connective tissue growth factor expression in primary cultures of human tubular epithelial cells: modulation by hypoxia |
Q42200808 | Chronic renoprotective effect of pulsatile perfusion machine RM3 and IGL-1 solution in a preclinical kidney transplantation model |
Q33520113 | Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway |
Q21296774 | E-cadherin/β-catenin complex and the epithelial barrier |
Q40219212 | EMMPRIN expression is involved in the development of interstitial fibrosis and tubular atrophy in human kidney allografts |
Q90884788 | ETS2 promotes epithelial-to-mesenchymal transition in renal fibrosis by targeting JUNB transcription |
Q51731677 | Effect of polyethylene glycol-based preservation solutions on graft injury in experimental kidney transplantation. |
Q39242491 | Epithelial to Mesenchymal Transition (EMT) and Endothelial to Mesenchymal Transition (EndMT): Role and Implications in Kidney Fibrosis |
Q34817706 | Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside? |
Q92831688 | Epithelial to mesenchymal transition in endomyocardial biopsies from orthotopic heart transplant recipients |
Q84605086 | Epithelial-mesenchymal transition in kidney grafts |
Q39437395 | Erbin inhibits TGF-β1-induced EMT in renal tubular epithelial cells through an ERK-dependent pathway |
Q30405394 | Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction |
Q37638064 | Fibrogenesis in kidney transplantation: potential targets for prevention and therapy |
Q36647033 | Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates |
Q89848874 | Growth Differentiation Factor 15 in Children with Chronic Kidney Disease and after Renal Transplantation |
Q36877844 | HSP27 is involved in the pathogenesis of kidney tubulointerstitial fibrosis |
Q54114281 | Induction of myosin light chain kinase and CPI-17 by TGF-β accelerates contractile activity in intestinal epithelial cells. |
Q47717684 | Inhibition of coagulation proteases Xa and IIa decreases ischemia-reperfusion injuries in a preclinical renal transplantation model |
Q31149306 | Inhibition of the K+ channel K(Ca)3.1 reduces TGF-β1-induced premature senescence, myofibroblast phenotype transition and proliferation of mesangial cells |
Q90474075 | Kidney allograft fibrosis: what we learned from latest translational research studies |
Q50612339 | Kidney graft outcome using an anti-Xa therapeutic strategy in an experimental model of severe ischaemia-reperfusion injury. |
Q37591422 | Kidney transplantation: analysis of the expression and T cell-mediated activation of latent TGF-β. |
Q98775657 | Laser capture microdissection on formalin-fixed and paraffin-embedded renal transplanted biopsies: Technical perspectives for clinical practice application |
Q88972845 | Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition |
Q84456236 | Microarray gene expression profiling of chronic allograft nephropathy in the rat kidney transplant model |
Q37724869 | Molecular pathways involved in loss of graft function in kidney transplant recipients. |
Q36010095 | New insights into epithelial-mesenchymal transition in kidney fibrosis |
Q36611193 | Nox-2 is a modulator of fibrogenesis in kidney allografts |
Q35770306 | Phenolic secoiridoids in extra virgin olive oil impede fibrogenic and oncogenic epithelial-to-mesenchymal transition: extra virgin olive oil as a source of novel antiaging phytochemicals. |
Q51728385 | Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis. |
Q47944361 | Premature senescence and cellular phenotype transformation of mesangial cells induced by TGF-B1. |
Q28074230 | Redox control of senescence and age-related disease |
Q56704568 | Reduction of chronic rejection of renal allografts by anti-transforming growth factor-β antibody therapy in a rat model |
Q46132415 | Relation of urinary gene expression of epithelial-mesenchymal transition markers with initial events and 1-year kidney graft function |
Q36012598 | Reversal of transforming growth factor-β induced epithelial-to-mesenchymal transition and the ZEB proteins |
Q34756991 | Role of Sema4C in TGF- 1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells |
Q39251967 | SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner |
Q37696794 | Salt-induced epithelial-to-mesenchymal transition in Dahl salt-sensitive rats is dependent on elevated blood pressure |
Q37160141 | Superoxide overproduction and kidney fibrosis: a new animal model. |
Q38724337 | TGF-β: the connecting link between nephropathy and fibrosis |
Q43218265 | Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells |
Q36476527 | Tubular expression of heat-shock protein 27 inhibits fibrogenesis in obstructive nephropathy |
Q52720613 | Vimentin expression is required for the development of EMT-related renal fibrosis following Unilateral Ureteral Obstruction in mice. |
Q53624421 | [The epithelial-mesenchymal transition and fibrosis of the renal transplant]. |
Search more.